Oncology Central provides an authoritative resource for all stakeholders – including clinicians, care providers, laboratory scientists, and senior managers – to keep abreast of clinical, regulatory, scientific, technical and business updates in the fast-moving, global field of oncology.

Contact us now to discuss your marketing needs.

Why sponsor or advertise with us?

We take the time to understand what your needs are, who you are looking to communicate with, and why, so we can make sure we offer you the correct services to guarantee you achieve your goals. Ninety percent of our readers work in cancer care or research, 40% of whom are practising physicians. We create personalized & targeted campaigns that meet your marketing needs and offer dedicated support throughout. Our in-house editorial and design teams ensure the optimal message is delivered; our readers certainly think so:

“Congratulations for Oncology Central, a splendid idea and excellently presented. There are a few platforms around keeping the same idea, but yours is outstanding. Again I lift my hat and please continue with this medical scientific approach” – Kurt, Private Universität Witten

“Congratulations on your wonderful website…I have been progressively impressed with your education efforts in oncology along with the likes of Dr Jame Abraham and my colleagues across the pond.” – Swami Padmanabhan Iyer, MD

Packages and opportunities: 

• Targeted email campaigns
• Expert interviews
• Webinars
• Sponsored educational content
• White papers, case studies, thought leadership
• Company news hosting & promotion
• Display & print advertising
• Sponsored newsletters


Want to find out more about promotion on Oncology Central? Email or call the Oncology Central sales team:

Email: sales@oncology-central.com
Telephone: +44 (0)20 8371 6090

Download our 2019 media pack

Stay up to date

Upcoming event

Gastrointestinal Cancers Symposium

January 17, 2019 – January 19, 2019


View all
Upcoming event

International Symposium on Focal Therapy and Imaging in Prostate and Kidney Cancer

February 9, 2019 – February 11, 2019

Kyoto, Japan

View all

Results from the DART clinical trial indicate that ipilimumab plus nivolumab may be beneficial to patients with high-grade #neuroendocrinecarcinoma. Click the image below for the full news story: https://t.co/2C7epMD2Aq

View all

Connecting talent with opportunity. View our featured jobs

View all